A detailed history of Isthmus Partners, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Isthmus Partners, LLC holds 95,730 shares of JNJ stock, worth $14.9 Million. This represents 1.69% of its overall portfolio holdings.

Number of Shares
95,730
Previous 95,730 -0.0%
Holding current value
$14.9 Million
Previous $14 Million -0.0%
% of portfolio
1.69%
Previous 1.74%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 06, 2024

SELL
$144.38 - $157.78 $31,763 - $34,711
-220 Reduced 0.23%
95,730 $14 Million
Q1 2024

May 07, 2024

BUY
$155.22 - $162.74 $3.44 Million - $3.61 Million
22,194 Added 30.09%
95,950 $15.2 Million
Q4 2023

Feb 12, 2024

BUY
$145.6 - $158.88 $640,785 - $699,230
4,401 Added 6.35%
73,756 $11.6 Million
Q3 2023

Nov 14, 2023

BUY
$155.75 - $174.48 $176,776 - $198,034
1,135 Added 1.66%
69,355 $10.8 Million
Q2 2023

Aug 03, 2023

BUY
$154.35 - $166.11 $168,395 - $181,226
1,091 Added 1.63%
68,220 $11.3 Million
Q1 2023

May 10, 2023

BUY
$151.05 - $180.26 $286,692 - $342,133
1,898 Added 2.91%
67,129 $10.4 Million
Q4 2022

Feb 10, 2023

SELL
$160.2 - $179.79 $130,562 - $146,528
-815 Reduced 1.23%
65,231 $11.5 Million
Q3 2022

Nov 14, 2022

BUY
$161.33 - $179.52 $31,943 - $35,544
198 Added 0.3%
66,046 $10.8 Million
Q2 2022

Aug 08, 2022

BUY
$168.19 - $186.01 $112,350 - $124,254
668 Added 1.02%
65,848 $11.7 Million
Q1 2022

May 04, 2022

BUY
$158.14 - $179.59 $362,615 - $411,799
2,293 Added 3.65%
65,180 $11.6 Million
Q4 2021

Jan 25, 2022

BUY
$155.93 - $173.01 $153,435 - $170,241
984 Added 1.59%
62,887 $10.8 Million
Q3 2021

Nov 10, 2021

BUY
$161.5 - $179.47 $82,365 - $91,529
510 Added 0.83%
61,903 $10 Million
Q2 2021

Aug 10, 2021

SELL
$159.48 - $171.07 $172,716 - $185,268
-1,083 Reduced 1.73%
61,393 $10.1 Million
Q1 2021

May 17, 2021

SELL
$153.07 - $170.48 $135,313 - $150,704
-884 Reduced 1.4%
62,476 $10.3 Million
Q4 2020

Feb 16, 2021

BUY
$137.11 - $157.38 $34,003 - $39,030
248 Added 0.39%
63,360 $9.97 Million
Q3 2020

Nov 04, 2020

BUY
$140.38 - $153.83 $14,038 - $15,383
100 Added 0.16%
63,112 $9.4 Million
Q2 2020

Aug 10, 2020

SELL
$128.81 - $155.51 $13,396 - $16,173
-104 Reduced 0.16%
63,012 $8.86 Million
Q1 2020

May 15, 2020

SELL
$111.14 - $153.99 $47,012 - $65,137
-423 Reduced 0.67%
63,116 $8.28 Million
Q4 2019

Feb 07, 2020

SELL
$127.5 - $146.44 $68,977 - $79,224
-541 Reduced 0.84%
63,539 $9.27 Million
Q3 2019

Nov 14, 2019

BUY
$126.95 - $142.14 $72,996 - $81,730
575 Added 0.91%
64,080 $8.29 Million
Q2 2019

Aug 09, 2019

BUY
$131.15 - $144.24 $8.33 Million - $9.16 Million
63,505 New
63,505 $8.85 Million
Q1 2019

Apr 19, 2019

SELL
$125.72 - $139.79 $7.58 Million - $8.43 Million
-60,302 Closed
0 $0
Q4 2018

Feb 04, 2019

BUY
$122.84 - $147.84 $192,981 - $232,256
1,571 Added 2.67%
60,302 $7.78 Million
Q3 2018

Nov 14, 2018

BUY
$121.58 - $142.88 $54,467 - $64,010
448 Added 0.77%
58,731 $8.12 Million
Q2 2018

Aug 02, 2018

BUY
$119.4 - $131.76 $54,804 - $60,477
459 Added 0.79%
58,283 $7.07 Million
Q1 2018

May 11, 2018

BUY
$125.1 - $148.14 $28,773 - $34,072
230 Added 0.4%
57,824 $7.41 Million
Q4 2017

Feb 05, 2018

SELL
$131.22 - $143.62 $84,243 - $92,204
-642 Reduced 1.1%
57,594 $8.05 Million
Q3 2017

Nov 02, 2017

BUY
$129.47 - $135.38 $7.54 Million - $7.88 Million
58,236
58,236 $7.57 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $406B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Isthmus Partners, LLC Portfolio

Follow Isthmus Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Isthmus Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Isthmus Partners, LLC with notifications on news.